Atara Biotherapeutics Inc

Biotech Stocks Healthcare Stocks

$10.48

+0.67 (+6.83%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 2 20%

Sell 1 10%

Price Target

Analyst Price Target -32.8% upside

Low Target $5.84

Average Target $7.04

High Target $9.41

Current Price $10.48

Current
$10.48

Target
$7.04

$5.84 $7.04 avg $9.41

Scenario Analysis

Bear Case

$5.84

-44.3%

Low target

Base Case

$7.04

-32.8%

Avg target

Bull Case

$9.41

+-10.2%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$19.15

-45.3% from high

52-Week Low

$3.92

+167.3% from low

Target vs 52W High

$7.04

-63.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%